MK

Mahendra Kumar

Active Director Director DIN 07508065
DIN 07508065 First appointment Jun 2016 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2016
Shareholding value •••• Premium profile

About Mahendra Kumar

Data last updated:

Mahendra Kumar is a Director at Zenixo Pharma Private Limited (since 2016). The company operates in Healthcare. Zenixo Pharma Private Limited reported revenue of ₹10,000 (FY 2022).

DIN 07508065
Primary Designation Director
Industry Healthcare
First Appointment 07 Jun 2016
Oldest Company Age 10 yrs
Largest company Zenixo Pharma Private Limited · ₹10,000 (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zenixo Pharma Private Limited U74900UP2016PTC083870
Director07 Jun 20162016₹10,000 (FY 2022)Active

Board colleagues of Mahendra Kumar

NameDINCompanyDesignation
Ashutosh Singh07508119Zenixo Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Zenixo Pharma Private Limited
Premium access

Shareholding and investment profile for Mahendra Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahendra Kumar

Mahendra Kumar currently holds 1 directorship: Zenixo Pharma Private Limited (Director, since 07 Jun 2016, revenue ₹10,000 (FY 2022)).

Mahendra Kumar was first appointed on 07 Jun 2016 as Director at Zenixo Pharma Private Limited.

The current boards of Mahendra Kumar's companies include Ashutosh Singh (Zenixo Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available